CPHI & PMEC China 2026
06/2026 – 06/2026
About Company
- Legal Name: JIANGSU GTIG HUATAI CO.,LTD
- Registered country: China
- Address: 15-16/F., Huachang Oriental Plaza, Renmin Road, Zhangjiagang City
- Number of employees: 50 - 99
Description:
Jiangsu GTIG Huatai Co., Ltd. is one of China's top 500 companies, specializing in intermediates and APIs for Sofosbuvir, Ledipasvir, Velpatasvir, Venetoclax, Obeticholic Acid, Palbociclib, Glecaprevir, Dolutegravir, Alectinib, Eribulin Mesylate, Bictegravir, Niraparib, Ribociclib, Dabigatran etexilate mesylate, Sacubitril, Vilanterol, Umeclidinium Bromide, Indacaterol, Ibrutinib, Baricitinib and Pazopanib, among others, with any patent-related products supplied for research purposes only.
Business Activities
Natural Extracts & Herbal Ingredients
Distributor
Pharma Chemicals
Distributor
ATC (Anatomical Therapeutic Chemical) Classification
Distributor
Innovator APIs
Distributor
Sales Markets
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Key Products/Services
Our Products & Services
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Proofs
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment